Studies conducted over a decade ago provided insights into the distinct natural history of these subtypes of APL, showing major differences in the capacity of the PML/RARA and PLZF/RARA fusion proteins to bind corepressor complexes according to the level of retinoic acid. The gene discussed is PML; the disease is acute promyelocytic leukemia.